Stephenson, Diane
Critical Path Institute
14 papers on CoChatORCID 0000-0002-4262-436X
Most cited papers
- Verified
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis
Stephenson, D. T., O'Neill, S. M., Narayan, S., Tiwari, A., Arnold, E., Samaroo, H. D., Du, F., Ring, R. H., Campbell, B., Pletcher, M., et al. (2011) · Molecular Autism
Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental Disorders
Cited by 180
- Verified
Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study
Adams, J. L., Kangarloo, T., Tracey, B., O’Donnell, P., Volfson, D., Latzman, R. D., Zach, N., Alexander, R., Bergethon, P., Cosman, J., et al. (2023) · npj Parkinson's Disease
Parkinson's Disease Mechanisms and TreatmentsContext-Aware Activity Recognition Systems
Cited by 98
- Verified
Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510)
Yang, D., Xie, Z., Stephenson, D., Morton, D., Hicks, C. D., Brown, T. M., Sriram, R., O'Neill, S., Raunig, D., & Bocan, T. (2011) · NeuroImage
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 64
- Verified
Understanding Placebo Responses in Alzheimer's Disease Clinical Trials from the Literature Meta-Data and CAMD Database
Ito, K., Corrigan, B., Romero, K., Anziano, R., Neville, J., Stephenson, D., & Lalonde, R. (2013) · Journal of Alzheimer's Disease
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 62
- Verified
Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of action
Lanz, T. A., Guilmette, E., Gosink, M. M., Fischer, J. E., Fitzgerald, L. W., Stephenson, D. T., & Pletcher, M. T. (2013) · Molecular Autism
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 52
- Verified
The qualification of an enrichment biomarker for clinical trials targeting early stages of Parkinson’s disease
Stephenson, D., Hill, D., Cedarbaum, J. M., Tome, M., Vamvakas, S., Romero, K., Conrado, D. J., Dexter, D. T., Seibyl, J., Jennings, D., et al. (2019) · Journal of Parkinson’s Disease
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 46
- Verified
Mapping Relevance of Digital Measures to Meaningful Symptoms and Impacts in Early Parkinson’s Disease
Mammen, J. R., Speck, R. M., Stebbins, G. M., Müller, M. L. T. M., Yang, P. T., Campbell, M., Cosman, J., Crawford, J. E., Dam, T., Hellsten, J., et al. (2023) · Journal of Parkinson’s Disease
Parkinson's Disease Mechanisms and TreatmentsHealth Education and Validation
Cited by 38
- Verified
Charting a path toward combination therapy for Alzheimer’s disease
Stephenson, D., Perry, D., Bens, C., Bain, L. J., Berry, D., Krams, M., Sperling, R., Dilts, D., Luthman, J., Hanna, D., et al. (2015) · Expert Review of Neurotherapeutics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 37
- Verified
Identifying and characterising sources of variability in digital outcome measures in Parkinson’s disease
Roussos, G., Herrero, T. R., Hill, D. L., Dowling, A. V., L. T. M. Müller, M., Evers, L. J. W., Burton, J., Derungs, A., Fisher, K., Kilambi, K. P., et al. (2022) · npj Digital Medicine
Mobile Health and mHealth ApplicationsParkinson's Disease Mechanisms and Treatments
Cited by 28
- Verified
Accelerating Parkinson’s Disease drug development with federated learning approaches
Khanna, A., Adams, J., Antoniades, C., Bloem, B. R., Carroll, C., Cedarbaum, J., Cosman, J., Dexter, D. T., Dockendorf, M. F., Edgerton, J., et al. (2024) · npj Parkinson's Disease
Privacy-Preserving Technologies in DataParkinson's Disease Mechanisms and Treatments
Cited by 21
- Verified
Challenges in Alzheimer’s Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data
Conrado, D. J., Duvvuri, S., Geerts, H., Burton, J., Biesdorf, C., Ahamadi, M., Macha, S., Hather, G., Francisco Morales, J., Podichetty, J., et al. (2020) · Clinical Pharmacology & Therapeutics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 21
- Verified
Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’s
Mammen, J. R., Lerner, A., Al-Rubayie, R., Kostrzebski, M., Stephenson, D., Xiao, Y., Redmond, C., Tyo, M., Reddy, V. G., Auinger, P., et al. (2025) · Journal of Neurology
Parkinson's Disease Mechanisms and TreatmentsBalance, Gait, and Falls Prevention
Cited by 18
- Verified
Empowering drug development: Leveraging insights from imaging technologies to enable the advancement of digital health technologies
Izmailova, E. S., Maguire, R. P., McCarthy, T. J., Müller, M. L. T. M., Murphy, P., & Stephenson, D. (2023) · Clinical and Translational Science
Artificial Intelligence in Healthcare and EducationStatistical Methods in Clinical Trials
Cited by 17
- Verified
Developing digital health technologies for frontotemporal degeneration
Nevler, N., Niehoff, D., Gleixner, A. M., Dodge, S., Vogel, A. P., Hill, D. L., Ducharme, S., Staffaroni, A. M., Yunusova, Y., Au, R., et al. (2025) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchMobile Health and mHealth Applications
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free